Organophosphorus compounds
Medchemexpress LLC EMU-116 | 2241724-59-2 | 98.53% | 405.58 | 25 MG
EMU-116 is an orally active CXCR4 antagonist. It is utilized in cancer research.
- Orally active CXCR4 antagonist
- Can be used in cancer research
- Purity of 98.53%
- Molecular weight of 405.58
- Appears as a solid
- Color is light yellow to yellow
- Powder storage at -20°C for 3 years, 4°C for 2 years
- In solvent storage at -80°C for 6 months, -20°C for 1 month
- Soluble in DMSO at 100 mg/mL
- Multiple in vivo dissolution protocols available
Medchemexpress LLC hsa-miR-195-3p inhib 5nmol | 5nmol
hsa-miR-195-3p inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs The miRNA inhibitors have full-length nucleotide 2 -methoxy modification The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes thereby inhibiting miRNAs from functioning
Strem, An Ascensus Company CAS# 116-17-6. 50g. Tri-i-propylphosphite, min. 94%. MFCD00008874
CAS# 116-17-6. 50g. Tri-i-propylphosphite, min. 94%. MFCD00008874. Molecular Weight: 208.24. Molecular Formula: [(CH3)2CHO]3P. Color/form: colorless liq. Strem# 15-7000. http://www.strem.com/catalog/v/15-7000/
Medchemexpress LLC LEP(116-130)(mouse) | 258276-95-8 | 99.2% | 1560.73 | 5 MG
LEP(116-130)(mouse) is a synthetic leptin peptide fragment intended for research use only. It has been shown to reduce body weight gain and blood glucose levels in vivo.
- Unable to inhibit AP-OB binding in vitro
- Reduces rate of body weight gain in vivo despite increased food intake
- Significantly reduces blood glucose levels by approximately 100 mg/dL in vivo
- No effect on the ability to thermoregulate in wild-type mice
